Epidermal and transforming growth factor alpha in patients with breast tumours.

[1]  J. Young,et al.  The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action , 1988, Regulatory Peptides.

[2]  D. Orth,et al.  Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma. , 1987, Biochemical and biophysical research communications.

[3]  D. Goeddel,et al.  Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .

[4]  H. Gregory,et al.  Acceleration of wound healing by recombinant human urogastrone (epidermal growth factor). , 1986, The Journal of laboratory and clinical medicine.

[5]  R. Derynck,et al.  Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation. , 1985, Cancer research.

[6]  D. Salomon,et al.  Purification of a mammary-derived growth factor from human milk and human mammary tumors. , 1985, The Journal of biological chemistry.

[7]  H. Gregory.  In Vivo Aspects of Urogastrone-Epidermal Growth Factor , 1985, Journal of Cell Science.

[8]  D. Salomon,et al.  Presence of transforming growth factors in human breast cancer cells. , 1984, Cancer research.

[9]  L. Hood,et al.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.

[10]  M. Sporn,et al.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Fujita,et al.  Urinary Excretion of Human Epidermal Growth Factor (hEGF) in Patients with Malignant Tumors , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  G. Todaro,et al.  Growth factors from murine sarcoma virus-transformed cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Barnes,et al.  Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. , 1977, European journal of cancer.

[14]  H. Gregory.  Isolation and structure of urogastrone and its relationship to epidermal growth factor , 1975, Nature.

[15]  S. Cohen,et al.  The primary structure of epidermal growth factor. , 1972, The Journal of biological chemistry.

[16]  J. Tsai,et al.  Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma. , 1987, Cancer research.

[17]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[18]  D. Twardzik,et al.  High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. , 1983, Cancer research.